Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production

Convit, 1993, The clinical and immunological spectrum of American cutaneous leishmaniasis, Trans R Soc Trop Med Hyg, 87, 444, 10.1016/0035-9203(93)90030-T

Sacks, 2002, The immunology of susceptibility and resistance to Leishmania major in mice, Nat Rev Immunol, 2, 845, 10.1038/nri933

Carvalho, 1995, Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis, Am J Trop Med Hyg, 53, 273, 10.4269/ajtmh.1995.53.273

Trujillo, 2002, Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis, Parasite Immunol, 24, 455, 10.1046/j.1365-3024.2002.00488.x

Bourreau, 2001, High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment, J Infect Dis, 184, 1628, 10.1086/324665

Caceres-Dittmar, 1993, Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction, Clin Exp Immunol, 91, 500, 10.1111/j.1365-2249.1993.tb05931.x

Louzir, 1998, Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major, J Infect Dis, 177, 1687, 10.1086/515297

Pirmez, 1993, Cytokine patterns in the pathogenesis of human leishmaniasis, J Clin Invest, 91, 1390, 10.1172/JCI116341

Salhi, 2008, Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis, J Immunol, 180, 6139, 10.4049/jimmunol.180.9.6139

Junqueira Pedras, 2003, Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis, Diagn Microbiol Infect Dis, 47, 477, 10.1016/S0732-8893(03)00141-X

Romero, 2005, Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil, Acta Trop, 93, 49, 10.1016/j.actatropica.2004.09.005

Rodriguez, 1996, The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell-mediated immune response, Parasite Immunol, 18, 341, 10.1046/j.1365-3024.1996.d01-113.x

Melby, 1994, Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis, Infect Immun, 62, 837, 10.1128/iai.62.3.837-842.1994

Rodrigues, 1998, Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis, Infect Immun, 66, 1233, 10.1128/IAI.66.3.1233-1236.1998

Anderson, 2005, Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice, J Immunol, 174, 2934, 10.4049/jimmunol.174.5.2934

Chatelain, 1999, Leishmania major infection in interleukin-4 and interferon-gamma depleted mice, Parasite Immunol, 21, 423, 10.1046/j.1365-3024.1999.00240.x

de Souza-Neto, 2004, Leishmania braziliensis: Partial control of experimental infection by interleukin-12 p40 deficient mice, Mem Inst Oswaldo Cruz, 99, 289, 10.1590/S0074-02762004000300009

Ajdary, 2000, Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection, Infect Immun, 68, 1760, 10.1128/IAI.68.4.1760-1764.2000

Stenger, 1994, Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major, J Exp Med, 180, 783, 10.1084/jem.180.3.783

Diaz, 2003, Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis, Clin Exp Dermatol, 28, 288, 10.1046/j.1365-2230.2003.01206.x

Qadoumi, 2002, Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis, Infect Immun, 70, 4638, 10.1128/IAI.70.8.4638-4642.2002

Cabrera, 1995, Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis, J Exp Med, 182, 1259, 10.1084/jem.182.5.1259

Da-Cruz, 1996, Tumor necrosis factor-alpha in human American tegumentary leishmaniasis, Mem Inst Oswaldo Cruz, 91, 225, 10.1590/S0074-02761996000200019

Heinzel, 1991, Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis, Proc Natl Acad Sci U S A, 88, 7011, 10.1073/pnas.88.16.7011

Sadick, 1990, Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody, J Exp Med, 171, 115, 10.1084/jem.171.1.115

Coutinho, 1998, Immunologic patterns associated with cure in human American cutaneous leishmaniasis, Braz J Med Biol Res, 31, 139, 10.1590/S0100-879X1998000100019

Chatelain, 1999, Experimental Leishmania major infection in mice: Role of IL-10, Parasite Immunol, 21, 211, 10.1046/j.1365-3024.1999.00224.x

Padigel, 2003, The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis, J Immunol, 171, 3705, 10.4049/jimmunol.171.7.3705

Belkaid, 2002, CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, 420, 502, 10.1038/nature01152

Rocha, 1999, Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis, J Infect Dis, 180, 1731, 10.1086/315071

Campanelli, 2006, CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells, J Infect Dis, 193, 1313, 10.1086/502980